By targeting these molecules or their downstream gene products, researchers might be able to enhance macrophage function in ...
The Oxford coronavirus vaccine shows a strong immune response in adults in their 60s and 70s, raising hopes that it can protect age groups most at risk from the virus. Researchers say the Lancet ...
TUESDAY, Dec. 3, 2024 (HealthDay News) -- A newly approved immunotherapy can help adults with a difficult-to-treat form of ...